This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
Erickson C. A. et al. (2011)
A prospective open-label study of aripiprazole in fragile X syndrome.
Psychopharmacology (Berl)
July, 216(1), pp. 85-89.
Erickson C. A. et al. (2011)
An open-label naturalistic pilot study of acamprosate in youth with autistic disorder
Journal of Child and Adolescent Psychopharmacology
Erickson C. A. et al. (2010)
Aripiprazole in autism spectrum disorders and fragile X syndrome.
Neurotherapeutics
7(3), pp. 258-263
Erickson C. A. , Mullett J. , McDougle C. J. (2010)
Brief report: acamprosate in fragile X syndrome.
Journal of Autism and Developmental Disorders
40(11), pp. 1412-1416.
Erickson C. A. et al. (2014)
Journal of Autism and Developmental Disorders
April, 44(4), pp. 981-987.
Erickson C. A. et al. (2005)
Gastrointestinal factors in autistic disorder: a critical review.
Journal of Autism and Developmental Disorders
35(6), pp. 713-727
Erickson C. A. , Mullett J. E. , McDougle C. J. (2009)
Open-label memantine in fragile X syndrome.
Journal of Autism and Developmental Disorders
39(12), pp. 1629-1635.
Hazen E. P. et al. (2014)
Sensory symptoms in autism spectrum disorders.
Harvard Review of Psychiatry
22(2), pp. 112-24.
Klaeger D. , McDougle C. J. (2000)
Secretin in autism— a parent’s perspective.
Journal of Autism and Developmental Disorders
30(1), pp. 72-73.
Kowalski J. et al. (2011)
Paliperidone palmitate in a child with autistic disorder.
Journal of Child and Adolescent Psychopharmacology
October, 21(5), pp. 491-493
Lindsay R. L. et al. (2006)
Journal of Intellectual and Developmental Disability
December, 31(4), pp. 204-209.
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
American Journal of Psychiatry
161(6), pp. 1125-1127
McCracken J. T. et al. (2002)
Risperidone in children with autism and serious behavioral problems.
New England Journal of Medicine
347(5), pp. 314-321